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ABSTRACT 25 
 Bacteria belonging to the genus Cronobacter (C.) have been recognized as 26 
causative agents of life-threatening systemic infections primarily in premature, low-27 
birth weight and immune-compromised neonates. Elucidation and validation of 28 
putative bacterial virulence components as well as host factors possibly involved in 29 
the response to infection has been hampered in the past by the availability of suitable 30 
neonatal animal models. In the current study the recently developed zebrafish 31 
embryo model was employed to study the interaction of the zinc metalloprotease Zpx 32 
present in Cronobacter spp. with MMP-9, a protease cleaving extracellular matrix 33 
gelatin and collagen. RT-PCR revealed differential expression of the zebrafish mmp-34 
9 upon infection with Cronobacter, as well as an increase of the processed, active 35 
form of the MMP-9 over the course of infection. Employing a C. turicensis zpx knock 36 
out mutant revealed that the presence of this bacterial protease induces the 37 
expression of the mmp-9 but also increases the levels of processed MMP-9 during 38 
infection. Most striking, experiments using a morpholino knock down of zebrafish 39 
mmp-9 suggest involvement of the MMP-9 in induction of the expression of the 40 
bacterial protease. This study identified host MMP-9 as a substrate of Zpx and 41 
demonstated yet undescribed mutual cross-talk between these two proteases in 42 
Cronobacter mediated infections. 43 
 44 
 45 
 46 
 47 
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INTRODUCTION 48 
 Cronobacter represents a genus of opportunistic pathogens that can cause 49 
severe infections predominantly in pre-term and/or immune compromised neonates 50 
for which high fatality rates ranging between 40 and 80% have been reported1. 51 
Clinical manifestations of infection include necrotizing enterocolitis, septicemia and 52 
neonatal meningitis and pneumonia1. Current knowledge of the pathogenesis as well 53 
as the host response elicited of these bacteria remains to be elucidates, a feature 54 
that particularly applies to those host factors that may be involved during infection.  55 
  Matrix metalloproteases (MMPs) such as MMP-9, are involved in the 56 
migration of inflammatory cells across the extracellular matrix, as well as contributing 57 
to tissue remodeling2,3. It has been shown that levels of MMP-9 increase rapidly, in 58 
blood circulaton of mice and the serum of healthy human volunteers, following the 59 
introduction of E. coli LPS4,5.  In addition, it was demonstrated that MMP-9 deficiency 60 
protects against mortality in a murine endotoxic shock model, and selective blocking 61 
of MMP-9 was suggested as a potential novel therapeutic approach for treatment of 62 
sepsis5. However, in other studies a protective role of MMP-9 against infections 63 
caused by E. coli and Listeria has been reported and this discrepancy in results was 64 
explained by the existance of a well-regulated balance between inflammatory 65 
processes, necessary to combat invading pathogens and overshooting inflammation 66 
which can result in tissue damage6,7. 67 
 In addition to induction of MMP-9 secretion by the host, the activation of pro-68 
MMP-9 can be triggered by releasing bacterial proteolytic enzymes. Thus activation 69 
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of MMP-9 has been reported from serine proteases associated with LPS 70 
preparations8. Streptococcus pneumoniae the major cause of severe pneumonia, 71 
secretes a zinc metalloproteinase ZmpC which cleaves MMP-9 in vitro. In a murine 72 
pneumonia model ZmpC mutants caused 75% less mortality than wild-type 73 
pneumococci, confirming a role of ZmpC in pathogenesis9.  74 
 In Cronobacter, a zinc metalloprotease Zpx was identified and characterized 75 
by Kothary et al.10 and its role as a virulence factor during in vivo infection was 76 
confirmed by Eshwar et al11. In the latter study, the recently developed zebrafish 77 
embryo infection model was used to study sepsis caused by Cronobacter 11,12.  78 
 In the current study we wanted explore the involvement of the MMP-9 in 79 
Cronobacter pathogenesis as well to investigate its interaction between zpx and 80 
MMP-9 in vivo using the zebrafish embryo sepsis model.   81 
 82 
MATERIALS AND METHODS 83 
Bacterial strains. 84 
  The bacterial strains used in this study are listed in Supplemental Table T1. C. 85 
turicensis LMG 23827T , is a clinical isolate responsible for the death of two neonates 86 
in Zurich 200613 and the GFP expressing variant was constructed by Schmid et al.14. 87 
Construction of the C. turicensis LMG 23827T Δzpx mutant, the complemented 88 
mutant C. turicensis LMG 23827T Δzpx/pQE30::zpx as well as the mutant carrying 89 
the expression vector plasmid pQE30 only is described in detail by Eshwar et al.11 C. 90 
muytjensii LMG 51329TdsRED was constructed by transformation of the strain with 91 
plasmid pRZT3::dsRED. E. coli Xl1 blue was transformed either with the plasmid 92 
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pQE30 (the original vector) or plasmid pQE30::zpx constructed earlier by Eshwar et 93 
al. (2016), using standard molecular techniques. Bacteria were grown at 37 °C in 94 
Luria-Bertani (LB) broth with shaking (210 rpm) or on LB agar supplemented with the 95 
respective antibiotics: ampicillin (100 mg L-1), tetracycline (30 mg L-1) and nalidixic 96 
acid (256 mg L-1)(Supplemental Table T1). 97 
 For microinjection experiments, the bacteria were grown to stationary phase in 98 
LB overnight at 37 °C, harvested by centrifugation at 5,000 x g for 10 min and 99 
washed once in 10 ml of Dubelcco`s phosphate buffered saline (DPBS, Life 100 
Technologies.) After a second centrifugation step, the cells were resuspended in 101 
DPBS, and appropriate dilutions were prepared in DPBS.   102 
 103 
Zebrafish lines and husbandry 104 
 Zebrafish (Danio rerio) wik lines were used in this study. Husbandry, breeding 105 
and bacterial inoculum preparation was performed following the procedure described 106 
by Eshwar et al.11 Virulence was assessed by determination of the survival rate (30 107 
embryos per experiment/strain) over 72 (hpi) hours post infection (= 3 days post 108 
infection, dpi). The following controls were included: infection with (apathogenic) E. 109 
coli Xl1 blue, injections with Dulbecco’s Phosphate Buffered Saline (DPBS), and non-110 
injected embryos. Microinjections of bacteria were performed using borosilicate glass 111 
microcapillary injection needles (Science Products, 1210332, 1 mm O.D. x 0.78 mm 112 
I.D.) and a PV830 Pneumatic PicoPump (World Precision Instruments). 113 
The maximum age reached by the embryos during experimentation was 114 
120 hpf (hours post fertilization = 72 hpi) for which no license is required from the 115 
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cantonal veterinary office since embryos had not yet reached free feeding stage.  116 
 117 
Infection studies 118 
 Two-dpf (days post fertilization) embryos were manually dechorionated and 119 
anesthetized with 200 mg L-1 buffered tricaine (MS-222) prior to the introduction of 120 
bacteria. Subsequently, embryos were aligned on an agar plate and injected with 121 
50 CFU of either C. turicensis, C. muytjensii, or E. coli (range 42 – 66 CFU) in 1-2 nl 122 
of a bacterial suspension in DPBS into the yolk sac. The number of CFU injected at 123 
0 hpi was determined by disintegrating and plating 5 embryos individually 124 
immediately after microinjection of bacteria (0 hpi) which resulted in an accurate 125 
determination of the numbers of CFU actually injected. 126 
 Following injections infected embryos were allowed to recover in a petri dish 127 
with fresh E3 medium for 15 min. To follow infection kinetics and for survival assays, 128 
embryos were transferred into 24-well plates (one embryo per well) in 1 ml E3 129 
medium per well, incubated at 28 °C and observed for signs of disease and survival 130 
under a stereomicroscope twice a day. For survival assays after infection, the 131 
number of dead larvae was determined visually based on the absence of heartbeat.  132 
At each time point, usually 0, 24, 48 and 72 hpi, five embryos were collected and 133 
individually treated for bacterial enumeration.  134 
 The maximum age reached by the embryos during experimentation was 120 135 
hpf (72 hpi) for which no license is required from the cantonal veterinary office since 136 
embryos had not yet reached free feeding stage.  137 
 138 
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Bacterial enumeration by plate counting 139 
 Three larvae were transferred to a separate 1.5-ml Eppendorf tube containing 140 
1 ml DPBS supplemented with 1% Triton X- 100 and disintegrated by repeated 141 
pipetting and vortexing for 3 minutes. These were subsequently, serially diluted and 142 
100 µl of the respective mixture was plated onto LB selective plates. Plates were 143 
incubated up to 48 h at 37 °C and CFU were determined. 144 
 145 
Mmp-9 silencing in zebrafish embryos by morpholino 146 
 Yolk sacs of one-cell stage zebrafish embryos were microinjected with 147 
concentrations of 500, 250, 125, 50 mM translation-blocking zebrafish mmp-9 148 
morpholino (MMP-9-MO, 5’- CGC CAG GAC TCC AAG TCT CAT TTT G -3’) and off-149 
target control human β-globin antisense morpholino (Control-MO, 5’-CCT CTT ACC 150 
TCA GTT ACA ATT TAT A-3’) (Gene Tools, USA).  Some of the morpholino injected 151 
embryos were sacrificed at 24, 72 and 96 hpi (= 1, 2 and 3 days post fertilization, 152 
dpf). 153 
 154 
RNA isolation and quantitative reverse transcription PCR  155 
 Forty (infected, non-infected) embryos from each group (C. turicensis, C. 156 
muytjensii, E. coli or mock-infected group) were collected at specified time points and 157 
re-suspended in 0.5 ml of the lysis buffer of the RNeasyPlus Mini Kit (Qiagen). The 158 
samples were mechanically disrupted for 1 min at 6,500 rpm using lysing bead matrix 159 
in MagNA lyser tubes using the MagNA Lyser Instrument (Roche Molecular 160 
Diagnostics, Rotkreuz, Switzerland). RNA was isolated from (infected/non-infected) 161 
zebrafish embryo and/or bacterial lysates following the RNeasy Plus Mini Kit protocol 162 
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(Qiagen). Genomic DNA was removed by using a genomic DNA binding column 163 
followed by an on column DNAse I digestion. Ambion's MICROBEnrich kit was used 164 
to enrich bacterial RNA from mixed host-bacterial RNA populations which selectively 165 
depletes host cell RNA, leaving behind highly enriched bacterial RNA. RNA was 166 
eluted in 50 µl of RNAse-free water, and subsequently quantified and quality 167 
controlled using the Nanodrop and BioAnalyzer instruments, respectively. The 168 
Quantitect Reverse Transcription Kit (Qiagen) was used to reverse transcribe 100 ng 169 
of RNA into cDNA. Residual DNA contamination was ruled out in each RNA sample 170 
by including a control in which the RT enzyme was omitted. Reverse transcription 171 
quantitative-PCR (RT-qPCR) was performed to determine the expression levels of 172 
genes in zebrafish and in bacteria injected into zebrafish. Some 2.5 ng cDNA was 173 
used to perform quantitative PCR using the primers that are listed in Supplemental 174 
Table T2 and SYBR green I kit (Roche Molecular Diagnostics) in the LC480 (Roche 175 
Molecular Diagnostics) instrument.  176 
 Quantification was performed using the Light Cycler 480 Relative 177 
Quantification Software (Roche Molecular Diagnostics). The mRNA levels were 178 
normalized using 16S rRNA as reference gene for bacteria and β-actin for zebrafish. 179 
 180 
Western blot analysis 181 
 Forty embryos from each group (C. turicensis, C. muytjensii, E. coli or mock-182 
infected group) were collected and resuspended in RIPA lysis buffer with protease 183 
inhibitor cocktail (Cell Biolabs Inc, San Diego, USA). The samples were mechanically 184 
disrupted for 1 min at 6,500 rpm using lysing bead matrix in MagNA lyser tubes using 185 
the MagNA Lyser Instrument (Roche Molecular Diagnostics, Rotkreuz, Switzerland). 186 
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The concentration of protein in each sample was determined using Nanodrop Protein 187 
A280 protocol. For western blot analysis, 20 µg lysate per sample was suspended in 188 
Laemmli Sample Buffer (Biorad, Cressier, Switzerland), and heated to 95 °C for 189 
5 min. Subsequently, samples were subjected to sodium dodecyl sulfate (SDS)–190 
polyacrylamide gel electrophoresis (PAGE) and western blot analysis using MMP-9 191 
rabbit polyclonal primary antibody (Aviva systems biology, San Diego, USA) and 192 
HRP-conjugated anti-rabbit IgG secondary antibody using standard techniques 193 
(BioRad technical protocol). ImageJ software (National Institute of Health, USA) was 194 
used for densitometry determinations to asses fold differences in the protein levels 195 
from Western blots. 196 
 197 
Statistical analysis 198 
 Kaplan Meier survival analysis and statistics for experiments with zebrafish 199 
was done with GraphPad Prism 7 (GraphPad Software, United States). Experiments 200 
were performed in triplicates.  201 
 202 
RESULTS  203 
 Expression of mmp-9 in zebrafish embryos during infection with 204 
Cronobacter turicensis.  205 
 The expression of mmp-9 was monitored in zebrafish embryos injected with C. 206 
turicensis, C. muytjensii and E. coli at 24 and 41 hpi. Experiments with C. muytjensii 207 
were included as it was reported from previous studies that this strain is an 208 
apathogenic member of the Cronobacter species11. Injection with C. turicensis 209 
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induces the expression of zebrafish mmp-9 to a much higher (> 3 fold) extent than 210 
the two other bacterial strains at both time points investigated (Figure 1). In addition, 211 
expression of the mmp-9 increases in C. turicensis over the course of infection but 212 
decreases in infections with the C. muytjensii and E. coli.  213 
 214 
Figure 1: Expression (as determined by qRT-PCR) analysis of bacterial mmp-9 in 215 
zebrafish embryos during infection with the three bacterial strains shown along with 216 
experimental controls. 217 
 218 
Analysis of MMP-9 protein levels during infection with Cronobacter and E. coli 219 
 Western blot analysis was performed on zebrafish embryos infected with C. 220 
turicensis in order to determine the presence of pro-MMP-9 (92-kDa) and its 221 
processed form (77-kDa) over the course of infection. As shown in Figure 2, both 222 
forms are clearly detected at 6 hpi. However, the intensity of the pro-MMP-9 band 223 
appears decrease in intensity whilst the MMP-9 band at-77 kDa increases. This 224 
observation suggests the presence of higher amounts of processed/activated MMP-9 225 
at the later time points during infection. The intensity of the β-actin band (control, 42 226 
kDa) remained unaltered over the same time course.  227 
 228 
Figure 2: Western blot analysis to detect the presence of pro-MMP-9 and processed 229 
MMP-9 at several time points during infection with C. turicensis. 230 
 231 
 In a next step the presence and amount of pro-MMP-9 and the activated form 232 
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of MMP-9 in zebrafish embryos injected with C. turicensis, C. muytjensii and E. coli at 233 
time point 48 hpi (= 2 dpi) was investigated. Levels of activated MMP-9, as 234 
determined by this method and as shown in quantitative data obtained from the 235 
Western blot (Figure 3), were significantly lower in embryos injected with C. 236 
muytjensii and E. coli. This result supports the qRT-PCR expression data from Figure 237 
1. 238 
 239 
Figure 3: (A): Western blot analysis of pro-MMP-9 and its processed form MMP-9, 240 
along with β-actin (control) in embryos injected with C. turicensis, C. muytjensii and 241 
E. coli at time point 48 hpi. (B): quantification of the band for the processed MMP-9 242 
(77 kDa). 243 
 244 
Silencing of mmp-9 in zebrafish embryos. 245 
 For a detailed analysis, mmp-9 morphants were created in zebrafish embryos. 246 
In a first step, the amount of morpholino that had to be injected to silence mmp-9 247 
expression was determined by Western blot analysis using antibodies directed 248 
against zebrafish MMP-9 and β-actin (control). Experiments using a nonsense 249 
morpholino were carried out to show, that the knock down of mmp-9 was the result of 250 
injection of the MMP-9 morpholino directly into the embryos. In Supplementary 251 
Figure S1 results of experiments of embryos injected with varying amounts of 252 
morpholino are shown. Both MMP-9 related bands disappear when 500 nm 253 
morpholino was injected. This injection dose was used for further experiments.  254 
 255 
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MMP-9 contributes to Zebra fish model protection against Cronobacter 256 
infection by controlling bacterial load. 257 
 Survival experiments were carried out on wt zebrafish and their isogenic mmp-258 
9 morphants infected with C. turicensis, C. muytjensii and E. coli. At 1-day post 259 
infection (dpi) survival rates of 80 % and 50 % were observed in wt embryos and 260 
morphants respectively in infection experiments with C. turicensis, suggesting that 261 
MMP-9 may function to combat bacterial infection during the early stage of infection. 262 
However, zero percent survival was determined in both wt and morphant embryos at 263 
2 dpi (Figure 4). A protective effect of MMP-9 was also observed in experiments 264 
using the “apathogenic” C. muytjensii strain wherein survival rates dropped from 100 265 
% in wt embryos to 60 % in morphants at 3 dpi (Figure 4). In contrast, survival rates 266 
in infections using E. coli remained unaltered in both groups of embryos. 267 
 268 
Figure 4: Survival data of wt embryos (ZF wt) and mmp-9 morphants (ZF morphant) 269 
shown when infected with C. turicensis, C. muytjensii and E. coli. 270 
 271 
 Based on these observations it would be reasonable to hypothesize that 272 
MMP-9 may play a role in the killing of the bacterial pathogen at the early stages of 273 
infection. This theory was further tested, experimentally by assessing the success or 274 
otherwise when using various bacterial doses over the course infection, again with 275 
these three bacterial strains. These data are shown in Supplemental Figure S2. 276 
During infections with Cronobacter strains the bacterial load was increased in mmp-9 277 
morphants, thus highlighting a role of MMP-9 in killing of Cronobacter cells during the 278 
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early phase of infections in vivo. However, this effect was not observed with E. coli 279 
indicating that this organism was incapable of growing in zebrafish embryos.    280 
  281 
C. turicensis Zpx mediates expression of mmp-9. 282 
  q-RT-PCR experiments with embryos infected with the delta zpx C. turicensis 283 
mutant clearly showed a reduced expression of mmp-9, whereas expression was 284 
restored to a certain degree in embryos infected with the C. turicensis zpx 285 
complemented mutant (Figure 5). Elevated expression of MMP-9 was also observed 286 
in embryos injected with E. coli carrying the C. turicensis wt zpx gene in trans, thus 287 
supporting the latter finding (Figure 5). 288 
 289 
Figure 5: Transcriptional expression (as measured by qRT-PCR analysis) of mmp-9 290 
in zebrafish embryos during infection with C. turicensis wt, the delta zpx mutant, the 291 
mutant complemented with the wt zpx, E. coli wt and E. coli carrying the C. turicensis 292 
zpx gene as well as controls at 24 hpi. 293 
 294 
MMP-9 triggers the expression of the C. turicensis zpx 295 
 In order to study the possible influence that MMP-9 might exert on zpx 296 
expression, qRT-PCR assays were performed in WT and mmp-9 morphants embryos 297 
infected with C. turicensis, the C. turicensis mutant complemented with zpx and E. 298 
coli carrying C. turicensis zpx gene in trans at 24 hpi. Expression of zpx was 299 
significantly reduced in morphants during infections with all strains tested (Figure 6). 300 
In a control experiment, zpx expression was determined when the three strains were 301 
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injected into human β-actin antisense (control) morphants. In these experiments zpx 302 
expression levels were similar to the ones observed in injected wt zebrafish 303 
(Supplemental Figure S3).  304 
   305 
Figure 6: Transcriptional expression (as measured by qRT-PCR analysis) of zpx in 306 
C. turicensis wt, the zpx mutant complemented with the wt zpx, as well as E. coli 307 
carrying the C. turicensis wt zpx in zebrafish embryos and mmp-9 morphants at 24 308 
hpi during in vivo infection conditions.  309 
 310 
MMP-9 negatively affects survival of embryos during infection with zpx 311 
depleted C. turicensis 312 
 To further examine the possible interaction of C. turicensis Zpx and zebrafish 313 
MMP-9, infection experiments were carried out with wt embryos and mmp-9 314 
morphants which were injected with C. turicensis wt, the zpx mutant and the 315 
complemented mutant as well as E. coli carrying the C. turicensis zpx gene in trans. 316 
Survival rates in mmp-9 morphants were found to be higher (80 %) than in wt 317 
embryos (60 %) in infections with the zpx depleted C. turicensis strain at 3 dpi 318 
(Figure 7A). This finding suggested a potential interplay existed between the bacterial 319 
Zpx and the host MMP-9. Higher survival rates of zebrafish wt embryos (40 %) 320 
versus morphants (30 %) were observed in infections with E. coli carrying C. 321 
turicensis zpx, a finding that appears to support our working hypothesis (Figure 7B). 322 
 323 
Figure 7: Survival data of wt zebrafish embryos and MMP-9 morphants during 324 
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infections with (A) C. turicensis, C. turicensis delta zpx, C. turicensis delta zpx 325 
complemented with the C. turicensis zpx and controls. (B) E. coli Xl1 blue, E. coli Xl1 326 
blue carrying the C. turicensis zpx gene in trans and controls over 72 hpi.  327 
 328 
C. turicensis Zpx processes pro MMP-9 in vivo 329 
 We hypothesized that the C. turicensis Zpx may be involved in the processing 330 
of pro-MMP-9 in vivo. The results of the respective analysis are depicted in Figure 9. 331 
Presence of C. turicensis Zpx (in the respective strains) resulted in a stronger band 332 
for the processed MMP-9 as analysed by Western blot analysis, which was also 333 
confirmed by densidometric measurements of the band representing the processed 334 
MMP-9 on the blot using the ImageJ software (National Institute of Health, USA). 335 
  336 
Figure 8: (A): Western blot analysis of pro-MMP-9 and processed forms in embryos 337 
injected with C. turicensis, the delta zpx mutant, the delta zpx mutant complemented 338 
with the C. turicensis zpx gene, E. coli carrying the C. turicensis zpx in trans and 339 
controls. (B): Densidometric data for the band representing the processed MMP-9 340 
(77-kDa) obtained by analysis using ImageJ software (National Institute of Health, 341 
USA). 342 
  343 
DISCUSSION 344 
 Matrix metalloproteinases (MMPs) have important functions in extracellular 345 
matrix (ECM) degradation and tissue repair15. MMP-9 has been found to contribute 346 
not only to gelatinase activity, but also to leukocyte migration, thus participating in 347 
mammalian inflammation and immunity16,17. MMP-9 in zebrafish is expressed notably 348 
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in the head-kidney and in peritoneal and peripheral blood leucocytes, indicating its 349 
role in immune responses18.  350 
 The current study demonstrated the involvement of zebrafish MMP-9 in 351 
countering early Cronobacter infections in zebrafish embryo models. In the study by 352 
Shan et al.7, migration of macrophages to the site of infection was markedly impaired 353 
in mmp-9 morphants in Listeria zebrafish infections resulting in rapid death and 354 
higher bacterial loads compared to infections in wt zebrafish. Survival rates of 50 % 355 
(morphants) and 80 % (wt) at 1dpi and higher bacterial loads at 24 and 48 hpi during 356 
infections with C. turicensis wt (Figure 8A, Supplementary Figure S2) suggest a 357 
similar mechanism in fighting early stages of infection. Further Shan et al. (2016) 358 
suggested activation of MMP-9 via a non-proteolytic mechanism as a mechanism to 359 
protect against infection. However, it has been shown in other studies that 360 
degradation of extracellular matrix proteins such as collagens by MMPs such as 361 
MMP-9 may promote migration of macrohages necessary to control infections19,20. 362 
Thus we hypothesize that MMP-9 is a crucial factor in controlling the bacterial load 363 
during the early stages of an infection possibly by recruiting (additional) 364 
macrophages in order to kill the intruder thereby preventing bacterial dissemination in 365 
the host. However, it has been shown in a study by Eshwar et al.21 that C. turicensis 366 
is capable of surviving and replicating in macrophages and it was suggested that 367 
macrophages may be used by the pathogens as vehicle to traverse from the site of 368 
infection to other parts of the body. The latter feature may explain why Cronobacter 369 
internalized in macrophages are protected during the later stages of infection while 370 
MMP-9 and/or other host components are no longer sufficient to combat infection 371 
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with C. turicensis.  372 
 In the second part of the study MMP-9 was identified as a substrate of the C. 373 
turicensis zinc metalloprotease Zpx. This protease was originally characterized in C. 374 
sakazakii ATCC 29544T by Kothary et al.10 and was found to be a member of the 375 
metzincin metalloprotease, that possesses collagenolytic activity. Thus, it was 376 
suggested that this factor may be responsible for necrosis and extensive cellular 377 
destruction in neonates with necrotizing enterocolitis but it may also be involved in 378 
allowing the organism to cross the blood-brain barrier. Eshwar et al.11 reported on the 379 
role of this virulence factor in zebrafish embryos infected with C. turicensis . In the 380 
same study survival data for infections with C. muytjensii (Enterobacter sakazakii) 381 
ATCC5132T was presented showing that it was virtually apathogenic despite the fact 382 
that this strain also possesses Zpx which, according to the data presented in the 383 
study by Kothary et al.10 should present a high activity in several in vitro assays 384 
applied in the study to determine the activity of this protease. However, results from 385 
the present study indicated that C. muytjensii is hardly, if at all growing/persisting in 386 
zebrafish embryos during infection, which may explain the low levels of mmp-9 387 
expression as well as the low level of processed MMP-9 determined in zebrafish 388 
infection experiments.  389 
 It has already been shown in a previous study that knock out of the C. 390 
turicensis zpx results in enhanced survival rates in wt. zebrafish embryos11. Results 391 
from the current study showed a similar phenotype also for infections with the zpx 392 
depleted C. turicensis strain in mmp-9 morphants (Figure 8A). In addition it was 393 
observed that C. turicensis Zpx induces the expression of MMP-9 and is capable of 394 
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processing pro-MMP-9 thus possibly activating its proteolytic properties. Higher 395 
survival rates in morphants versus wt embryos during infections with the zpx 396 
depleted C. turicensis strain over the whole observation period further supported the 397 
hypothesis of an interplay between these two molecules (Figure 8A). We 398 
hypothesisze that zpx induction of expression and activation of the MMP-9 may lead 399 
to uncontrolled action of MMP-9 resulting in additional adverse effects presented by 400 
this protease e.g. on extracellular tissues resulting in higher mortality rates. The latter 401 
“cumulative, adverse effect” of Zpx and MMP-9 may also account for higher mortality 402 
rates in mmp-9 morphants during infections with wt C. turicensis (expressing Zpx) 403 
observed at 1dpi. From our results we conclude, that Zpx expressed in C. turicensis 404 
may interfere with the tightly defined roles exhibited by host MMP-9 to fight infections 405 
by these organisms. However, the observation that expression of the bacterial zpx is 406 
mediated by host MMP-9 was somewhat unexpected and requires further 407 
investigation. 408 
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